A combination of radionuclide therapy and immunotherapy has proven successful in slowing the progression of prostate cancer and increasing survival time, according to new research published in the ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window MADRID -- ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window ORLANDO -- An ...
According to new research, a peptide receptor radiolabeled therapy (PRRT) is effective not only in decreasing tumor size but also in reducing the severity of side effects that often accompany a cancer ...
Bioorthogonal reactions are a series of chemical reactions that occur in biological environments with high yields, selectivity, efficiency, and no side reactions. These reactions include ...
If you would like to learn more about the IAEA’s work, sign up for our weekly updates containing our most important news, multimedia and more. “As the number of medical procedures needing ...
Transaxial slices of baseline positron emission tomography (PET) and fused PET/magnetic resonance imaging (MRI; left) demonstrate a somatostatin receptor-expressing meningioma in the left cavernous ...
BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology, Inc. (NASDAQ: CLVS), announced today that the first clinical site for the Phase 1/2 LuMIERE study of FAP-2286, its novel peptide-targeted radionuclide ...
Since its approval in 2018 by the US Food and Drug Administration, peptide receptor radionuclide therapy (PRRT) has become a mainstay in the treatment of neuroendocrine tumors. Lutetium-177-DOTATATE, ...
Research shows that combining targeted radionuclide therapy with immunotherapy could improve the survival of patients with metastatic melanoma. Research presented at the 2018 Annual Meeting of the ...
Since 2021, at the request of the Government of Japan, the Agency has been independently reviewing the safety of discharging advanced liquid processing system (ALPS) treated water from the Fukushima ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback